Nasdaq:US$17.69 (-2.18) | HKEX:HK$29.50 (-2.25) | AIM:£2.98 (-0.36)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice